Of the platforms compared here, Celebrus AI is the only one built from the ground up on a live, identity-resolved behavioral ...
Background Janus kinase inhibitors (JAKis) are emerging therapies for SLE, but concerns regarding thromboembolic risk persist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results